This site is intended for healthcare professionals only
This webcast series and supporting materials was developed by the Chronic Conditions faculty in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the agenda, speaker selection, presentations or collateral content, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.

Chronic Conditions Month 2022

The Big Debate

On-demand videos

Chair's Introduction

These video presentations were originally broadcast on the 4 May 2022.

Pleae note that the speakers are not able to answer questions from attendees watching the video on-demand

The Big Debate

These video presentations were originally broadcast on the 4 May 2022.

Pleae note that the speakers are not able to answer questions from attendees watching the video on-demand

Chronic Conditions Month 2022

The Big Debate

Join us for a series of interactive webinars and podcasts to help you optimise care for people with chronic conditions

The agenda

13:00–14:00

The Debate: A new era in chronic care: Managing long-term conditions in primary care, post-COVID

14:00–14:15

Live Q&A

14:15–15:00

The modern management of NVAF in patients with multimorbidity

This webinar is organised and funded by Boehringer Ingelheim; Product-related information will be discussed

PC-GB-106393 V2 | April 2022

The speakers

Dr Peter Bagshaw

Clinical Lead in Dementia and Mental Health, South Glos CCG, and Director of the South West Clinical Network for Dementia​

Sarah Davies

GPwSI in Diabetes, Cardiff

Dr Rob Hampton

Portfolio GP, Occupational Physician and GPwSI in Drug and Alcohol Treatment, Leicester

Dr Steve Holmes

GP, Shepton Mallet and Clinical Respiratory Lead, NHS England South West and NHS Somerset

Dr Sarah Jarvis MBE, FRCGP

GP, Medical Broadcaster and Clinical Director, Patient.info

Dr Yassir Javaid

Cardiovascular and Diabetes Lead, Northamptonshire CCG

Therapy webinar sponsor

We are Boehringer Ingelheim.
Family-owned. Purpose-led. Innovation-driven: We work to improve health for people and animals.

Aspiring to make new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Established in 1885, we have always been independent and family-owned, meaning we have the freedom to pursue our purpose – identifying health challenges of the future, and targeting areas of need where we can do the most good.

By working collaboratively, we aim to accelerate the delivery of medical breakthroughs to help transform the lives of patients now, and for generations to come. In the UK we do this through scientific innovation – taking on the biggest challenges in medicine. We invest in sustainable healthcare – planning for the long term alongside the NHS and our partners in the veterinary world. We support digital transformation by partnering with innovators to drive healthcare improvements.

We are committed to tackling the challenge of climate change. We serve local and global communities through our social impact programme and wevsupport social entrepreneurs who find healthcare solutions for the most vulnerable.

chronic-conditions-logo-white
© Copyright Omniamed Communications. All Rights Reserved 108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom